Nov
10
2024

Our mission | Daria Julkowska, ERDERA Scientific Coordinator

Daria Julkowska

For millions of people, rare diseases are more than just statistics—they are daily challenges, unanswered questions, and battles for better care. At ERDERA, our mission is simple but urgent: to improve the lives of over 30 million people living with rare diseases in Europe. In this video, Daria Julkoska, ERDERA’s Coordinator, explains the three essential ways how ERDERA plans to work towards a brighter future for people living with rare diseases.

News & Updates

You might also be interested in

30 million people in Europe live with a rare disease. Yet most still lack a diagnosis or treatment. So what is ERDERA doing about it?
ERDERA will launch its Clinical Trial Call 2026 (ECTC) on 1 July 2026, supporting multinational, GCP‑compliant early‑phase interventional clinical trials in rare diseases.
Pre-announcement describing scope, eligibility and indicative timeline for the ERDERA Clinical Trial Call 2026, expected to open on 1 July 2026.
Budget example showing low and high cost ranges for a Phase 1 rare disease clinical trial with twenty subjects.